Publisher
Akshantala Enterprises Private Limited
Reference35 articles.
1. Immunohistochemical evaluation of estrogen receptor status in benign prostatic hypertrophy and in prostate carcinoma and the relationship to efficacy of endocrine therapy;Konishi;Oncology,1993
2. [2] Shweikert H, Tunn U, Habenicht U, et al. Effects of estrogen deprivation on human benign prostatic hyperplasia. J Ster Biochem Molec Biol 1993;44(4-6):573-6.
3. [3] Matsushima H, Kitamura T, Gotu T, et al. Combined analysis with BCL - 2 and ERs immunostaining in prostatic carcinoma. Prostatic Cancer and Prostatic Diseases 2002;5:105-10.
4. [4] Tzifi F, Economopoulou C, Gourgiotis D, et al. The role of BCL - 2 family of apoptosis regulator proteins in acute and chronic leukemias. Adv Hematol 2012;2012:524308.
5. Functiona and physiological roles of two types of estrogen receptors, ERα and ERβ, identified by estrogen receptor knockout mouse;Lee;Lab Anim Res,2012